Detalles de la búsqueda
1.
A phase 1 study of inotuzumab ozogamicin in pediatric relapsed/refractory acute lymphoblastic leukemia (ITCC-059 study).
Blood;
137(12): 1582-1590, 2021 03 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-33067614
2.
Aneuploidy in children with relapsed B-cell precursor acute lymphoblastic leukaemia: clinical importance of detecting a hypodiploid origin of relapse.
Br J Haematol;
185(2): 266-283, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30714092
3.
Neurotoxic side effects in children with refractory or relapsed T-cell malignancies treated with nelarabine based therapy.
Br J Haematol;
179(2): 272-283, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28771662
4.
Durable remissions in TCF3-HLF positive acute lymphoblastic leukemia with blinatumomab and stem cell transplantation.
Haematologica;
104(6): e244-e247, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30765470
5.
Blinatumomab in pediatric relapsed/refractory B-cell acute lymphoblastic leukemia: RIALTO expanded access study final analysis.
Blood Adv;
6(3): 1004-1014, 2022 02 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34979020
6.
Inotuzumab ozogamicin as single agent in pediatric patients with relapsed and refractory acute lymphoblastic leukemia: results from a phase II trial.
Leukemia;
36(6): 1516-1524, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35468945
7.
Other (Non-CNS/Testicular) Extramedullary Localizations of Childhood Relapsed Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma-A Report from the ALL-REZ Study Group.
J Clin Med;
10(22)2021 Nov 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-34830574
8.
Risk factors and outcomes in children with high-risk B-cell precursor and T-cell relapsed acute lymphoblastic leukaemia: combined analysis of ALLR3 and ALL-REZ BFM 2002 clinical trials.
Eur J Cancer;
151: 175-189, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34010787
9.
Improving Stratification for Children With Late Bone Marrow B-Cell Acute Lymphoblastic Leukemia Relapses With Refined Response Classification and Integration of Genetics.
J Clin Oncol;
37(36): 3493-3506, 2019 12 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-31644328
10.
Correction: Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study.
Blood Cancer J;
11(10): 173, 2021 Oct 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-34707083
11.
Author Correction: Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study.
Blood Cancer J;
11(2): 28, 2021 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33563903
12.
Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study.
Blood Cancer J;
10(7): 77, 2020 07 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-32709851
13.
Blinatumomab versus historical standard therapy in pediatric patients with relapsed/refractory Ph-negative B-cell precursor acute lymphoblastic leukemia.
Leukemia;
34(9): 2473-2478, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32094465
Resultados
1 -
13
de 13
1
Próxima >
>>